CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,906
- in 7 filings
Net −$417,906. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-14 | RITTER DALE Vice President, Finance | Exercise or conversion | +12,500 | 19,827 | ||
| 2017-01-17 | RITTER DALE Vice President, Finance | Exercise or conversion · Restricted Stock Units | −12,500 | 37,500 | ||
| 2017-01-17 | RITTER DALE Vice President, Finance | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2016-03-22 | RITTER DALE Vice President, Finance | Grant or award · Stock Options (Right to Buy) | +40,000 | 40,000 | ||
| 2015-06-24 | RITTER DALE Vice President, Finance | Grant or award · Stock Options (Right to Buy) | +25,000 | $5.03 | $126K | 68,982 |
Page 1 of 1 · 5 trades